This study revealed beneficial effects against PD experimentally induced by rotenone, highlighting anti-inflammatory and anti-apoptotic properties in addition to its ability to reduce the expression of alpha synuclein, a pathological hallmark of PD [134]. Here, SNCA is linked to Parkinson disease.